Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis

Bryan Hambley, MD, Eric Gehrie, Jonathan Webster, MD, Margaret M. Showel, MD, Lukasz P. Gondek, MD PhD, William Brian Dalton, MD PhD, Gabrielle T. Prince, MD, Douglas E Gladstone, MD, Ivana Gojo, MD, Gabriel Ghiaur, MD PhD, Keith W. Pratz, MD, B. Douglas Smith, MD, Amy E. DeZern, MD, Mark J. Levis, MD

Blood (2019) 134 (Supplement_1): 3841.

https://doi.org/10.1182/blood-2019-123229

Published: 2019

Journal Articles

Effective Immunomodulation with Pomalidomide Beginning at Early Lymphocyte Recovery during Induction Timed Sequential Therapy (TST) for Acute Myeloid Leukemia (AML) and High-Risk Myelodysplasia (HR-MDS)

Joshua F Zeidner, MD, Hanna Knaus, MD, Amer M. Zeidan, MBBS, MHS, Amanda Blackford, Raul Montiel-Esparza, MD, Gabrielle T. Prince, MD, Lukasz P. Gondek, MD PhD, Gabriel Ghiaur, MD PhD, Margaret M. Showel, MD, Amy E. DeZern, MD, Keith W. Pratz, MD, B. Douglas Smith, MD, Mark J. Levis, MD, Matthew C Foster, MD, Catherine C. Coombs, MD, Howard Streicher, MD, Judith E. Karp, MD, Leo Luznik, MD, Ivana Gojo, MD

Blood (2018) 132 (Supplement 1): 335.

https://doi.org/10.1182/blood-2018-99-114961

Published: 2018

Journal Articles

FLT3 ITD AML Outcomes Are Impacted By Exposure to One Cycle of Cytarabine Based Consolidation, Pre- and Post-Transplant TKI Therapy, and Presence of Minimal Residual Disease (MRD) Prior to Allogeneic Blood or Marrow Transplant

Blood (2017) 130 (Supplement 1): 2593.

https://doi.org/10.1182/blood.V130.Suppl_1.2593.2593

Published: 2017

Journal Articles

Aberrant Hedgehog Signaling in Myelodysplastic Syndrome Accelerates Leukemic Transformation Via Smoothened-Dependent and Smoothened-Independent Gli1 Activation

Bonnie W Lau, MD PhD, Kyounghee Huh, MS, Rafael Madero-Marroquin, MD, Federico De Marchi, MD, Yiting Lim, PhD, Francisco Lobo, PhD, Luigi Marchionni, PhD, Peter D. Aplan, MD, William Matsui, MD, Lukasz P. Gondek, MD PhD

Blood (2017) 130 (Supplement 1): 1676.

https://doi.org/10.1182/blood.V130.Suppl_1.1676.1676

Published: 2017

Journal Articles

Protein Synthesis Rates Regulate Tumor-Initiating Potential and Chemoresistance in Multiple Myeloma

Eun-Hee Park, PhD, Mehrnoosh Soori, PhD MSc, Qiuju Wang, MSc, Lukasz P. Gondek, MD PhD, William Matsui, MD, Christian B. Gocke, MD PhD

Blood (2017) 130 (Supplement 1): 4390.

https://doi.org/10.1182/blood.V130.Suppl_1.4390.4390

Published: 2017

Journal Articles

Structural Chromosomal Changes Are Common Manifestation of FLT3 ITD Relapse and Presence of Chromosomal Progression Is Independent of Normal Karyotype at Diagnosis

Melanie Rebechi, BS, Wesley Hand, B. Douglas Smith, MD, Ivana Gojo, MD, Margaret M. Showel, MD, Gabrielle T Prince, MD, Douglas Gladstone, MD, Shannon R. McCurdy, MD, Gabriel Ghiaur, MD PhD, Lukasz P Gondek, MD PhD, Amy E. DeZern, MD MHS, Mark J. Levis, MD PhD, Keith W. Pratz, MD

Blood (2016) 128 (22): 2868.

https://doi.org/10.1182/blood.V128.22.2868.2868

Published: 2016

Journal Articles

Phase 1 Study of Pomalidomide Given at the Time of Early Lymphocyte Recovery after Induction Timed Sequential Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS)

Blood (2016) 128 (22): 2820.

https://doi.org/10.1182/blood.V128.22.2820.2820

Published: 2016

Journal Articles

Liberal Vs. Restrictive Transfusion Thresholds in Leukemia Patients: A Feasibility Pilot Study

Amy E. DeZern, MD MHS, Katherine Williams, Karen E. King, MD, Wesley Hand, Mark J. Levis, MD PhD, B Doug Smith, MD, Ivana Gojo, MD, Keith W. Pratz, MD, Lukasz P Gondek, MD PhD, Gabrielle T. Prince, MD, Gabriel Ghiaur, MD PhD, Margaret M. Showel, MD, Douglas Gladstone, MD, Steve Frank, Paul M. Ness, MD

Blood (2015) 126 (23): 771.

https://doi.org/10.1182/blood.V126.23.771.771

Published: 2015

Journal Articles

Aberrant Hedgehog Pathway Activity Marks Clinical MDS Progression and Accelerates Leukemic Transformation in Vivo

Lukasz P Gondek, MD PhD, Yiting Lim, PhD, Hideki Makishima, MD PhD, Qiuju Wang, MA, Jaroslaw P. Maciejewski, MD PhD FACP, Peter D Aplan, MD, Amy E. DeZern, MD MHS, William Matsui, MD

Blood (2014) 124 (21): 528.

https://doi.org/10.1182/blood.V124.21.528.528

Published: 2014

Journal Articles

FISH and SNP-Array Karyotyping Improve the Detection of Recurrent Chromosomal Defects Including Del(5q), Monosomy 7, Del(7q), Trisomy 8, and Del(20q) in Myelodysplastic Syndromes.

Hideki Makishima, MD, PhD, Manjot Rataul, MD, Lukasz P. Gondek, MD, PhD, Jungwon Huh, MD, James R. Cook, MD, PhD, Karl S. Theil, MD, Mikkael A Sekeres, MD, MS, Elizabeth Kuczkowski, Jaroslaw P. Maciejewski, MD, PhD

Blood (2008) 112 (11): 1483.

https://doi.org/10.1182/blood.V112.11.1483.1483

Published: 2008

Journal Articles

Clonal Hematopoiesis in Philadelphia Chromosome-Negative Bone Marrow Cells of Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors

Ron Paquette, MD, John Nicoll, Meenal Chalukya, Lukasz P Gondek, MD, PhD, Monika Jasek, Charles Sawyers, MD, Neil Shah, MD, PhD, Jaroslaw Maciejewski

Blood (2008) 112 (11): 575.

https://doi.org/10.1182/blood.V112.11.575.575

Published: 2008

Journal Articles

Investigations of Genetic Risk Factors in MDS and AML Using High- Density 6.0 Affymetrix Arrays

Bartlomiej P Przychodzen, Anna Malgorzata Jankowska, Sandra P Smieszek, Sanjay Ram Mohan, MD, Ramon V. Tiu, MD, BS, Monika Jasek, Lukasz P Gondek, MD, PhD, Jaroslaw P Maciejewski

Blood (2008) 112 (11): 638.

https://doi.org/10.1182/blood.V112.11.638.638

Published: 2008

Journal Articles

SNP-Array Based Karyotyping Complements Routine Cytogenetics in Diagnosis and Risk Stratification Schemes of MDS

Ramon V. Tiu, MD, BS, Lukasz P Gondek, MD, PhD, Jungwon Huh, MD, Christine O’Keefe, PhD, Mikkael A. Sekeres, MD, MS, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Michael A McDevitt, MD, PhD, Jaroslaw Maciejewski, MD, PhD

Blood (2008) 112 (11): 639.

https://doi.org/10.1182/blood.V112.11.639.639

Published: 2008

Journal Articles

Definition of Commonly Deleted Regions and Identification of Candidate Genes of Chromosome 20 in Myeloid Malignancies Using Genome-Wide Single Nucleotide Polymorphism (SNP) Array.

Jungwon Huh, MD, Ramon V. Tiu, MD, BS, Ying Jiang, MD, PhD, Lukasz P Gondek, MD, PhD, Christine O’Keefe, PhD, Karl S. Theil, MD, Jaroslaw P Maciejewski, MD, PhD

Blood (2008) 112 (11): 2056.

https://doi.org/10.1182/blood.V112.11.2056.2056

Published: 2008

NARROW

Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis

Effective Immunomodulation with Pomalidomide Beginning at Early Lymphocyte Recovery during Induction Timed Sequential Therapy (TST) for Acute Myeloid Leukemia (AML) and High-Risk Myelodysplasia (HR-MDS)

FLT3 ITD AML Outcomes Are Impacted By Exposure to One Cycle of Cytarabine Based Consolidation, Pre- and Post-Transplant TKI Therapy, and Presence of Minimal Residual Disease (MRD) Prior to Allogeneic Blood or Marrow Transplant

Aberrant Hedgehog Signaling in Myelodysplastic Syndrome Accelerates Leukemic Transformation Via Smoothened-Dependent and Smoothened-Independent Gli1 Activation

Protein Synthesis Rates Regulate Tumor-Initiating Potential and Chemoresistance in Multiple Myeloma

Structural Chromosomal Changes Are Common Manifestation of FLT3 ITD Relapse and Presence of Chromosomal Progression Is Independent of Normal Karyotype at Diagnosis

Phase 1 Study of Pomalidomide Given at the Time of Early Lymphocyte Recovery after Induction Timed Sequential Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS)

Liberal Vs. Restrictive Transfusion Thresholds in Leukemia Patients: A Feasibility Pilot Study

Aberrant Hedgehog Pathway Activity Marks Clinical MDS Progression and Accelerates Leukemic Transformation in Vivo

FISH and SNP-Array Karyotyping Improve the Detection of Recurrent Chromosomal Defects Including Del(5q), Monosomy 7, Del(7q), Trisomy 8, and Del(20q) in Myelodysplastic Syndromes.

Clonal Hematopoiesis in Philadelphia Chromosome-Negative Bone Marrow Cells of Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors

Investigations of Genetic Risk Factors in MDS and AML Using High- Density 6.0 Affymetrix Arrays

SNP-Array Based Karyotyping Complements Routine Cytogenetics in Diagnosis and Risk Stratification Schemes of MDS

Definition of Commonly Deleted Regions and Identification of Candidate Genes of Chromosome 20 in Myeloid Malignancies Using Genome-Wide Single Nucleotide Polymorphism (SNP) Array.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only